Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardIFRS
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥347.8bn2023-01-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.55T2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥346.8bn2022-01-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Operating income¥7.3bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥23.0bn2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥8.4bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥115.8bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥25.7bn2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥4.8bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥86.0bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥18.2bn2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥5.4bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥18.8bn2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥1.67Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.73Tat 2022-12-31Cons.Assets IFRS
Total assets¥1.69Tat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥687.8bnat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥731.0bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥977.6bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥995.4bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥998.0bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥983.9bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥951.5bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥972.1bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥977.7bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥216.8bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥268.2bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥281.9bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥336.1bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥2.8bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥130.9bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥10.1bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥15.1bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥74.9bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥15.7bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥37.0bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥139.3bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥38.9bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥10.362023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥183.282022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥38.52022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥10.362023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥183.272022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥38.52022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio57.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio56.3%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio58.0%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥220m
jpcrp040300-q1r_E00883-000Chemical Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥4.1bn
jpcrp040300-q1r_E00883-000Consumer Products Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥3.4bn
jpcrp040300-q1r_E00883-000Cosmetics Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥4.5bn
jpcrp040300-q1r_E00883-000Health And Beauty Care Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥5.8bn
jpcrp040300-q1r_E00883-000Hygiene And Living Care Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥2.7bn
jpcrp040300-q1r_E00883-000Life Care Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥620m
—segment totalsegment profit2023-01-01 → 2023-03-31¥7.5bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥124m
jpcrp040300-q1r_E00883-000Chemical Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥9.9bn
jpcrp040300-q1r_E00883-000Consumer Products Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥13.2bn
jpcrp040300-q1r_E00883-000Cosmetics Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥244m
jpcrp040300-q1r_E00883-000Health And Beauty Care Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥6.3bn
jpcrp040300-q1r_E00883-000Hygiene And Living Care Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥6.8bn
jpcrp040300-q1r_E00883-000Life Care Businessreportable segmentsegment profit2022-01-01 → 2022-03-31−¥186m
—segment totalsegment profit2022-01-01 → 2022-03-31¥23.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 734
ItemContextValueUnit
Net cash provided by used in financing activities IFRSPrior1YTDDuration-38943000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-36959000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSPrior1YTDDuration-64738000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSCurrentYTDDuration-54877000000JPY
Cash and cash equivalents IFRSPrior2YearInstant336069000000JPY
Cash and cash equivalents IFRSPrior1YearInstant268248000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration10598000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration3394000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant281929000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant216765000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember113930000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember80412000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000LifeCareBusinessReportableSegmentMember12231000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000CosmeticsBusinessReportableSegmentMember56360000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000ConsumerProductsBusinessReportableSegmentMember262933000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000ChemicalBusinessReportableSegmentMember83862000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReportableSegmentsMember346795000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY
Sales to external customers IFRSPrior1YTDDuration346795000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember-JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember-JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000LifeCareBusinessReportableSegmentMember-JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000CosmeticsBusinessReportableSegmentMember-JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000ConsumerProductsBusinessReportableSegmentMember-JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000ChemicalBusinessReportableSegmentMember10313000000JPY
Intersegment sales IFRSPrior1YTDDuration_ReportableSegmentsMember10313000000JPY
Intersegment sales IFRSPrior1YTDDuration_ReconcilingItemsMember-10313000000JPY
Intersegment sales IFRSPrior1YTDDuration-JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember113930000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember80412000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000LifeCareBusinessReportableSegmentMember12231000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000CosmeticsBusinessReportableSegmentMember56360000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000ConsumerProductsBusinessReportableSegmentMember262933000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000ChemicalBusinessReportableSegmentMember94175000000JPY
Net sales IFRSPrior1YTDDuration_ReportableSegmentsMember357108000000JPY
Net sales IFRSPrior1YTDDuration_ReconcilingItemsMember-10313000000JPY
Net sales IFRSPrior1YTDDuration346795000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember6818000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember6279000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000LifeCareBusinessReportableSegmentMember-186000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000CosmeticsBusinessReportableSegmentMember244000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000ConsumerProductsBusinessReportableSegmentMember13155000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00883-000ChemicalBusinessReportableSegmentMember9921000000JPY
Operating profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember23076000000JPY
Operating profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember-124000000JPY
Operating profit loss IFRSPrior1YTDDuration22952000000JPY
Finance income IFRSPrior1YTDDuration2412000000JPY
Finance costs IFRSPrior1YTDDuration566000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration856000000JPY
Profit loss before tax IFRSPrior1YTDDuration25654000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass